menu title
The Future of ART: Two-Drug Oral and Injectable Therapy
-
Presentation Downloads:Related Documents:Related Links:
Presentation Details:
The Future of ART: Two-Drug Oral and Injectable Therapy
• Discuss the future of antiretroviral therapy, which prioritizes two-drug options (and gather opinions on benefits vs. drawbacks of two-drug HIV treatment).
• Explain the newest data and developments in long-acting antiretroviral therapy and evolutions in our understanding of who may benefit from this therapy.
• Describe novel antiretroviral medications that are in development and likely coming in the near future.
Presented by:
Brian Wood, MD
Professor, Department of Medicine,
Division of Allergy & Infectious Diseases
Medical Director, MWAETC HIV ECHO Program
Associate Editor for the National HIV Curriculum and
National HIV PrEP Curriculum
University of Washington
The Future of ART: Two-Drug Oral and Injectable Therapy
• Discuss the future of antiretroviral therapy, which prioritizes two-drug options (and gather opinions on benefits vs. drawbacks of two-drug HIV treatment).
• Explain the newest data and developments in long-acting antiretroviral therapy and evolutions in our understanding of who may benefit from this therapy.
• Describe novel antiretroviral medications that are in development and likely coming in the near future.
Presented by:
Brian Wood, MD
Professor, Department of Medicine,
Division of Allergy & Infectious Diseases
Medical Director, MWAETC HIV ECHO Program
Associate Editor for the National HIV Curriculum and
National HIV PrEP Curriculum
University of Washington
Presentation Transcript: